Objectives/Goals: This study aims to assess perceptions of children with insulin-dependent diabetes and their guardians on the perceived benefits and challenges on the use of a diabetes-specific generative pretrained transformer to assist with diabetes care in insulin administration. Methods/Study Population: The study involved one-on-one semi-structured interviews with both adolescents aged 14-19 with insulin-dependent diabetes and their guardians. An interview guide was developed utilizing the constructs from the health information technology acceptance model. We have completed 1 interview with a caregiver with a child with diabetes. A total of 10 interviews are planned. All interviews have been or will be recorded utilizing a video conferencing platform and transcribed verbatim. The interview content will then be organized and coded using NVivo software. Thematic analysis was conducted in accordance with analysis guidelines. Results/Anticipated Results: From initial interviews, 3 key themes have arisen regarding the use of artificial intelligence for diabetes care. First, use of large language models has been utilized in their daily life; however, there is hesitancy to utilize these resources for medical advice. A second important theme that surfaced several times was the importance of trust in the source of the artificial intelligence that she would be using since it was for medical care. Another theme was the importance of ease of use of a large language model. This theme was illustrated by being able to share with family and friends since children are often involved with multiple caregivers. It would also have to have an easy-to-use interface, such as pre-programmed personal settings and recognizable picture icons to make her more likely to use it. Discussion/Significance of Impact: Users emphasized trust in AI sources for diabetes care, noting that clear visuals and personalization improve usability. Further interviews may reveal broader perspectives on adoption, challenges, and barriers among adolescents and caregivers with insulin-dependent diabetes.
Foster et al. (Wed,) studied this question.